HP
IMGN

HealthInvest Partners’s Immunogen Inc IMGN Stock Holding History

HealthInvest Partners’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$6.45K Buy
+1,300
New +$7.05K 0.01% 49

Other funds holding IMGN

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

HealthInvest Partners's IMGN Position: Q4 2022 in Review

HealthInvest Partners opened a new position in Immunogen Inc (IMGN) in Q4 2022: 1,300 shares worth $6.45K. The stake represents 0.01% of the portfolio and ranks #49 among its holdings.

204 funds tracked by Wall St. Rank hold IMGN as of Q4 2022.

  • HealthInvest Partners held 1,300 shares of Immunogen Inc worth $6.45K as of Q4 2022.
  • Immunogen Inc was a new HealthInvest Partners position in Q4 2022.
  • Immunogen Inc made up 0.01% of HealthInvest Partners's portfolio in Q4 2022, its #49 holding.
  • 204 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2022.

Based on HealthInvest Partners's 13F filing for Q4 2022, filed 14 Feb 2023.